Henry Schein stock holds steady ahead of next earnings update
Published on 08/29/2026 at 14:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Henry Schein Inc. (US42548G1040) stock is trading in a stable price zone as of August 28, 2026, with recent technical data showing the shares at $89.52 at the last market close and investors watching for the next set of earnings figures and guidance updates.
Share price and recent trading range
Recent technical data on Henry Schein shows the stock closing at $89.52 in the most recent completed session as of August 28, 2026, with the market described as closed at that level.
The same technical overview indicates that intraday levels referenced around the close were near $89.55 on that date, suggesting that Henry Schein stock is trading in a tight band close to the high-$80s to low-$90s range and not far from recent levels seen earlier in August 2026.
For investors, a price point of $89.52 positions Henry Schein shares within a moderate valuation zone compared with many larger health-care distributors, emphasizing the importance of upcoming earnings and guidance in determining whether this trading range will hold.
Earnings, revenue and margin context
The most recent earnings information accessible for Henry Schein indicates that the market is focused on the company’s latest quarterly revenue, earnings per share and margin performance, though specific fresh-period figures are not detailed in the present technical snapshot.
Historically, Henry Schein has reported annual revenue in the multibillion-dollar range and has emphasized operational efficiency and margin resilience in its filings and investor presentations, which remain part of the backdrop as investors prepare for the next quarterly release.
Compared with prior years, the current environment in late August 2026 puts more emphasis on how Henry Schein balances growth in its dental and medical distribution businesses against cost pressures and competitive dynamics, so any change in revenue growth or margins versus the previous fiscal year will draw attention.
Analyst and consensus perspective
Market commentary collected in late August 2026 suggests that analysts are watching Henry Schein’s fundamentals rather than expecting sharp short-term share price moves, aligning with the relatively steady trading near $89.52 as of August 28, 2026.
Consensus expectations ahead of the next reporting date are centered on stable earnings per share and incremental revenue growth, with attention on whether Henry Schein can show any acceleration versus its historical revenue trends or whether results simply match prior-year levels.
A key comparison point for the upcoming report will be whether Henry Schein’s new earnings figures exceed, match or fall short of the previous year’s quarter on metrics like revenue growth rate and operating margin, which will help investors judge whether the near-$90 share price appropriately reflects the company’s trajectory.
Core business and product focus
Henry Schein’s core business spans the distribution of dental and medical supplies, equipment and services, as well as technology solutions for clinics and practices, making it a diversified health-care products and services company serving professionals rather than consumers directly.
Within this portfolio, Henry Schein offers practice-management and digital imaging solutions that help dental and medical offices manage patient records, scheduling and diagnostics, contributing to recurring revenue streams and deeper customer relationships.
For investors, the performance of these technology and service offerings alongside traditional distribution lines is important because it can influence both revenue growth and margin stability in upcoming quarters.
Stock level and investor takeaway
As of August 28, 2026, the latest available technical snapshot indicates Henry Schein stock at $89.52 in the prior completed trading session, giving investors a clear reference level for evaluating future price moves once new earnings and guidance information are released.
Looking ahead, the combination of a stable share price in the high-$80s and the pending next earnings update means that Henry Schein stock could see more decisive moves if upcoming revenue and margin figures differ meaningfully from prior-year levels, making the next report a key catalyst for reassessing valuation.
Read more
Further information on Henry Schein’s financial performance, guidance and product portfolio is available through the company’s official investor communications and market data services that track the stock’s price history and fundamentals.
Fact box
Company: Henry Schein Inc.
ISIN: US42548G1040
Ticker: HSIC
Exchange: Nasdaq
Sector / Industry: Health care - medical distribution
